These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30265406)

  • 21. Management of gait impairments in people with Charcot-Marie-Tooth disease: A treatment algorithm.
    Nonnekes J; Hofstad C; de Greef-Rotteveel A; van der Wielen H; van Gelder JH; Plaats C; Altmann V; Krause F; Keijsers N; Geurts A; Louwerens JWK
    J Rehabil Med; 2021 May; 53(5):jrm00194. PubMed ID: 33880570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electromyographic and biomechanical analysis of step negotiation in Charcot Marie Tooth subjects whose level walk is not impaired.
    Lencioni T; Piscosquito G; Rabuffetti M; Sipio ED; Diverio M; Moroni I; Padua L; Pagliano E; Schenone A; Pareyson D; Ferrarin M
    Gait Posture; 2018 May; 62():497-504. PubMed ID: 29679921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease.
    Kennedy RA; Carroll K; McGinley JL; Paterson KL
    J Foot Ankle Res; 2020 Mar; 13(1):10. PubMed ID: 32122377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children.
    Pagliano E; Moroni I; Baranello G; Magro A; Marchi A; Bulgheroni S; Ferrarin M; Pareyson D
    J Peripher Nerv Syst; 2011 Sep; 16(3):237-242. PubMed ID: 22003938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orthopaedic shoes along with physical therapy was effective in Charcot-Marie-Tooth patient over 10 years.
    Bensoussan L; Jouvion A; Kerzoncuf M; Delarque A; Theodoridou E; Milhe de Bovis V; Thefenne L; Attarian S; Viton JM
    Prosthet Orthot Int; 2016 Oct; 40(5):636-42. PubMed ID: 26015326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of gait parameters in patients with Charcot-Marie-Tooth disease.
    Kuruvilla A; Costa JL; Wright RB; Yoder DM; Andriacchi TP
    Neurol India; 2000 Mar; 48(1):49-55. PubMed ID: 10751814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gait and footwear in children and adolescents with Charcot-Marie-Tooth disease: A cross-sectional, case-controlled study.
    Kennedy RA; McGinley JL; Paterson KL; Ryan MM; Carroll K
    Gait Posture; 2018 May; 62():262-267. PubMed ID: 29579702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscle fat quantification using magnetic resonance imaging: case-control study of Charcot-Marie-Tooth disease patients and volunteers.
    Kim HS; Yoon YC; Choi BO; Jin W; Cha JG
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):574-585. PubMed ID: 30873759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.
    Verhamme C; van Schaik IN; Koelman JH; de Haan RJ; de Visser M
    Brain; 2009 Dec; 132(Pt 12):3252-62. PubMed ID: 19843647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of progressive resistance exercise for Charcot-Marie-Tooth disease in children: a randomised, double-blind, sham-controlled trial.
    Burns J; Sman AD; Cornett KMD; Wojciechowski E; Walker T; Menezes MP; Mandarakas MR; Rose KJ; Bray P; Sampaio H; Farrar M; Refshauge KM; Raymond J;
    Lancet Child Adolesc Health; 2017 Oct; 1(2):106-113. PubMed ID: 30169201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of ankle function during gait in youth with Charcot-Marie-Tooth disease types 1 and 2.
    Õunpuu S; Pierz K; Mack WJ; Rodriguez-MacClintic J; Acsadi G; Wren TAL
    Gait Posture; 2023 Jun; 103():146-152. PubMed ID: 37167760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative assessment of sciatic nerve changes in Charcot-Marie-Tooth type 1A patients using magnetic resonance neurography.
    Fortanier E; Ogier AC; Delmont E; Lefebvre MN; Viout P; Guye M; Bendahan D; Attarian S
    Eur J Neurol; 2020 Aug; 27(8):1382-1389. PubMed ID: 32391944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.
    Morrow JM; Sinclair CD; Fischmann A; Machado PM; Reilly MM; Yousry TA; Thornton JS; Hanna MG
    Lancet Neurol; 2016 Jan; 15(1):65-77. PubMed ID: 26549782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postural instability in Charcot-Marie-Tooth 1A disease.
    Tozza S; Aceto MG; Pisciotta C; Bruzzese D; Iodice R; Santoro L; Manganelli F
    Gait Posture; 2016 Sep; 49():353-357. PubMed ID: 27491052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of muscle strength, balance and functionality of individuals with type 2 Charcot-Marie-Tooth Disease.
    de França Costa IMP; Nunes PS; de Aquino Neves EL; Lima Santos Barreto LC; Garcez CA; Souza CC; Pereira Oliveira PM; Sales Ferreira LA; Brandão Lima VN; de Souza Araújo AA
    Gait Posture; 2018 May; 62():463-467. PubMed ID: 29674285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical activity of children and adolescents with Charcot-Marie-Tooth neuropathies: A cross-sectional case-controlled study.
    Kennedy RA; Carroll K; Paterson KL; Ryan MM; Burns J; Rose K; McGinley JL
    PLoS One; 2019; 14(6):e0209628. PubMed ID: 31188833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional and dynamic response characteristics of a custom composite ankle foot orthosis for Charcot-Marie-Tooth patients.
    Dufek JS; Neumann ES; Hawkins MC; O'Toole B
    Gait Posture; 2014; 39(1):308-13. PubMed ID: 23958459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy.
    Shahrizaila N; Noto Y; Simon NG; Huynh W; Shibuya K; Matamala JM; Dharmadasa T; Devenney E; Kennerson ML; Nicholson GA; Kiernan MC
    Clin Neurophysiol; 2017 Jan; 128(1):227-232. PubMed ID: 27940147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of Charcot-Marie-Tooth disease type 1A duplication: a 2-year clinico-electrophysiological and lower-limb muscle MRI longitudinal study.
    Pelayo-Negro AL; Gallardo E; García A; Sánchez-Juan P; Infante J; Berciano J
    J Neurol; 2014 Apr; 261(4):675-85. PubMed ID: 24449066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.